Generic/ Brand Name Humulin R

  • May 2020
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Generic/ Brand Name Humulin R as PDF for free.

More details

  • Words: 941
  • Pages: 7
GENERIC/ BRAND NAME

DOSAGE & FREQUENCY

CLASSIFICATION

INDICATION

ACTION

ADVERSE REACTION

Humulin R

12 units IVTT

Insulin/ Antidiabetic agent

Treatment of DM for the control of hyperglycemia.

Rarely administer as the sole agent due to its short duration of action.

Local and generalized allergic reaction.

Captopril/ Capoten

500 mg SL now q 6 of BP > 140/90

Ace Inhibitor/ Antihypertensive

Hypertension, Heart Failure, MI.

Reduce BP; Onset;: 30 min or less

Amlodipine/ Norvasc

10g 1 tab BID 6 am

Calcium Channel Blocker

Hypertension, Myocardial Ischemia

Metoprolol/ Metoprolo Tartate

100 g 1 tab BID PO

Beta Blocker

Hypertension

Rash, Pruritus, Fever, wt loss, anemia, thrombocytopeni a, persistent cough Possible Headache, decrease edema, fatigue, in somnolence, myocardial nausea, contractility abdominal pain, . CO; is flushing, increase; dizziness, moderate palpitation. decrease in Peripheral vascular resistance. Exerts GI and Sleep mainly pattern Beta-1 disturbances,

REASON WHY IT IS GIVEN This drug is given because there is elevation in patient’s RBS and FBS Lab Result. This drug is given because the patient has unstable BP. This drug is given because the patients is hypertensive.

This drug is given because the

Atorvastatin/ Lipitor

80 g 1 tab TID

Antihyperlipidaemic / HMG-CoA Reductase inhibitors

Reduction of elevated total and HDL cholesterol in patient with primary hyper cholesterolemia, mixed hyperlipidemia.

Moramin S-2

1 tab TID

Parenteral Nutrition

Protein Caloric malnutrition (malabsorption sytndrome), malnutrition due to intake of protein. (e.g;

adrenergic blocking activity although Beta-2 receptors are blocked at high dosage. The HMGCoA reductase inhibitors competitiv ely inhibit HMG-CoA reductase. This increases the HDL cholesterol and decreases the LDL cholesterol .

rarely, nonspecific skin reaction and coldness of extremities.

patient is hypertensive.

GI disturbances, headache, myalgia, insomnia, muscle cramps, pruritus, constipation, flatus and bloating.

This drug lower the LDL cholesterol.

Hypersensitivity, GI upset, Chest discomfort, palpitation, chills, fever, heat sensation, headache,

This drug is given to correct the anorexia that the patient is manifesting.

Tramadol/ Dolcet

50 mg q 8 hr PO

Analgesic and Antipyretic

anorexia nervosa) Moderate-sever acute pain

Omeprazole/ Omepron

4 g 1 cap BID

Proton Pump Inhibitor

Antacids and Antiulcerant

NAME:

vascular pain. It may bind to muopiod receptors and inhibit reuptake of norepinephrine and serotonin.

Thought to be a gastric pump inhibitor in that blocks the final step of acid production.

ATTENDING PHYSICIAN:

CNS and GI disturbances, Nausea, Dizzines, comnolence, asthma, fatigue, hot flushes, constipation, diarrhea, flatulence, dry mouth, pruritus, tinnitus. Constipation, diarrhea, flatulence, nausea, vomiting, acid regurgitation, abdominal pain, headache, rash, chills, fever.

This drug is given to relieve the patients from manifesting pain.

This drug is given for prophylaxis of NSAID’s associated gastric ulcer with history of gastrodouden al lesions who require continued NSAID treatment. For treatment and prevention of the reoccurrence of GERD.

CC: DIAGNOSIS: DATE/ ASSESSMENT SHIFT July 30, 2009 3-11 9:00 pm

NEED P H Y S I O L O G I C N E E D/ Oxygenatio n

NAME:

DIET: RM #/BED: NURDING OBJECTIVE OF DIAGNOSIS CARE Ineffective After 2 hours of Breathing Nurse-Patient Pattern Interaction, the Related To patient will be able to:

NURSING INTERVENTION 1.Monitor VS. ® To obtain baseline data. 2.Administer Oxygen. ® To provide relief and minimize breathing  Establish a effort. 3.Position patient into normal Moderate or high back and rest as tolerated. effective respiratory ® To promote ease and maximize inspiration. pattern. 4.Encouraged slower  Be free of and deeper respiration, cyanosis used of pursed lip and other technique. signs of symptoms ® For the patient to of hypoxia. maximize respiratory effort. 5.Encouraged adequate rest periods between activities. ® To limit fatigue. 6.Encouraged increase OFI 1 Liter per day as indicated. ® To immobilize secretion and promote expectoration. ATTENDING PHYSICIAN:

EVALUATION

CC: DIAGNOSIS: DATE/ ASSESSMENT SHIFT July 30, 2009 3-11 9:00 pm

NEED P H Y S I O L O G I C N E E D/ Pain Avoidance

DIET: RM #/BED: NURDING OBJECTIVE OF DIAGNOSIS CARE Acute Pain After 2 hours of Related To Nurse-Patient Interaction, the patient will be able to:

NURSING INTERVENTION 1.Monitor VS. ® To obtain baseline data. 2.Assess location, duration, intensity (0-10 scale) and radiation. Note nonverbal signs, e.g., elevated BP and pulse,  Verbalize Relief from restlessness. ® This helps to evaluate pain. for the appropriate  Appears intervention. relaxed, and able to 3.Instruct the patient to notify caregivers of rest/sleep appropriat changes in pain occurrence and its ely. characteristics. ® this provides opportunity for timely administration of analgesia. 4.Provide comfort measures (e.g., backrub, restful environment). ® To promote relaxation, reduces muscle tension and enhances coping. 5.Encouraged used of focused breathing guided imagery or diversional activities.

EVALUATION

® this redirects attention and aids in muscle tension. 6.Administer medication as indicated. ®to manage the pain. 7.Apply warm compress as necessary to the affected site. ® Relieves muscle tension and may reduce reflex spasm.

NAME:

ATTENDING PHYSICIAN:

CC: DIAGNOSIS: DATE/ ASSESSMENT SHIFT July 30, 2009 3-11 9:00 pm

NEED P H Y S I O L O G I C N E E D/ ___

NURDING DIAGNOSIS Impaired Urinary Elimination Related To

DIET: RM #/BED: OBJECTIVE OF CARE After 6 hours of Nurse-Patient Interaction, the patient will be able to:

NURSING INTERVENTION EVALUATION

1.Monitor VS. ® To obtain baseline data. 2.Monitor I&O and characteristics of urine. ® Provide information about the kidney function and presence of other  Voids in complication. normal 3.Encouraged increase OFI amount and usual as indicated. ® increase hydration pattern. flushes bacteria and blood. 4.Investigat report of bladder fullness; palpate for suprapubic distention. Note decrease urine output. ® this indicate for possible development of further complication. 5.Maintain patency of indwelling catheters when used. ® Required to facilitate flow and prevent retention and corresponding complication.

Related Documents